Cell Paper: Genome-wide CRISPR Screen Reveal Host Factors Critical for SARS-CoV-2 Infection ProSci Incorporated’s ACE2 Antibody Published in Cell: ACE2 Rabbit Polyclonal Antibody for Western Blotting – COVID-19 (SARS-CoV-2) is a major public health threat with more than 1,200,000 deaths...
Share this post:
2019 Novel Coronavirus SARS-COV-2: The Emergence of COVID-19 At the end of 2019, Chinese authorities officially notified the World Health Organization about mysterious pneumonia infections. A week later, scientists identified a novel coronavirus with the full genome of SARS-COV-2 as...
Share this post:
August 2017: The Antibody Update – Zika has run its course for now Herd immunity to Zika virus in American populations is reported to have caused a tremendous decline in the number of cases this year. There was only one...
Share this post:
May 2017: The Antibody Update – Inhibition of Indolamine 2, 3 Dioxygenase (IDO) for Cancer Immunotherapy Researchers have found that a drug which inhibits IDO can increase the effectiveness of cancer immunotherapy. Epacadostat, which is an IDO inhibitor, successfully increased...
Share this post:
April 2017: The Antibody Update Frog-derived Hemagglutinin-Bearing Flu Antiviral An epidermal host defense peptide from the South Indian frog named urumin is virucidal for H1 hemagglutinin-bearing human influenza A viruses. It was demonstrated that this peptide destroyed influenza virions. It...
Share this post:
Caffeine is an Indirect Anti-Inflammatory Drug Interleukin-1β production is regulated by inflammasomes, a very large protein complex commonly associated with inflammation and pyroptosis. As the human body ages and accumulates metabolites, the inflammasome interacts with them and is primed for...
Share this post:
February 2017: The Antibody Update – Epidermal Levels of Staphylococcus Aureus Are Affected by a Peptide Produced by Other Skin Dwelling Bacteria Staphylococcus aureus is common to many of people’s skin microbiome, and is generally harmless; however, in high population...
Share this post:
January 2017: The Antibody Update – Mitigating the Reproducibility Crisis in Cancer Drug Research Reproducibility has been highlighted as one of the main problems when validating cancer research. Scientists with the The Reproducibility Project have opted to begin pragmatically reviewing...
Share this post:
Merck’s Ebola Vaccine is 100% Effective December 2016: The Antibody Update – An extremely effective Ebola virus vaccine created by Merck was recently tested in Guinea with 100% effectiveness. Though the vaccine is late for the worst part of the...
Share this post:
in China Perform First Injection of CRISPR Modified Cells into a Person Use of CRISPR-Cas9 in human cells for treatment of disease has been a controversial topic amongst scientists since the discovery of the powerful gene editing tool. In this...
Share this post:
